{"title":"Public database on pharmaceutical ties in Japan: Traffic and user attitudes on industry-professional relationships","authors":"Yosuke Suzuki , Anju Murayama , Akihiko Ozaki , Hiroaki Saito , Toyoaki Sawano , Erika Yamashita , Tetsuya Tanimoto","doi":"10.1016/j.hlpt.2024.100847","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>It is imperative to understand the specific details of the usage of the databases documenting financial ties between pharmaceutical companies and the healthcare sector and the attitudes of such database in evaluating how the citizens would recognize this issue. This study aimed to elucidate usage patterns and user attitudes regarding value transfers by analyzing data from the Yen For Docs Database in Japan (YDJ).</p></div><div><h3>Methods and Materials</h3><p>The study spanned the entire available data period, from January 15, 2019, to May 24, 2021, using Google Analytics to extract YDJ visitor data, including details on unique users, sessions, page views, and access paths over time. All visitors were invited to participate in a questionnaire survey gauging their attitudes towards value transfers from pharmaceutical firms to healthcare professionals. The survey data were analyzed separately for distinct groups, including non-healthcare or industry respondents, healthcare professionals, and those affiliated with pharmaceutical companies.</p></div><div><h3>Results</h3><p>YDJ received 604,903 accesses from 354,863 unique users, viewing 5,635,087 pages. Usage spiked initially and at later points. A survey of 399 respondents revealed negative views on value transfers from pharmaceutical companies, with over half finding it unethical. More than two-thirds supported stricter regulations. Non-healthcare respondents were less favorable compared to healthcare professionals and those affiliated with pharmaceutical companies.</p></div><div><h3>Conclusion</h3><p>YDJ achieved substantial user engagement, and the embedded questionnaire survey revealed prevalent critical perspectives among users regarding value transfers from pharmaceutical companies to the healthcare sector. Non-healthcare or industry respondents, in particular, expressed the most negative views about such relationships.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 2","pages":"Article 100847"},"PeriodicalIF":3.4000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211883724000108","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
It is imperative to understand the specific details of the usage of the databases documenting financial ties between pharmaceutical companies and the healthcare sector and the attitudes of such database in evaluating how the citizens would recognize this issue. This study aimed to elucidate usage patterns and user attitudes regarding value transfers by analyzing data from the Yen For Docs Database in Japan (YDJ).
Methods and Materials
The study spanned the entire available data period, from January 15, 2019, to May 24, 2021, using Google Analytics to extract YDJ visitor data, including details on unique users, sessions, page views, and access paths over time. All visitors were invited to participate in a questionnaire survey gauging their attitudes towards value transfers from pharmaceutical firms to healthcare professionals. The survey data were analyzed separately for distinct groups, including non-healthcare or industry respondents, healthcare professionals, and those affiliated with pharmaceutical companies.
Results
YDJ received 604,903 accesses from 354,863 unique users, viewing 5,635,087 pages. Usage spiked initially and at later points. A survey of 399 respondents revealed negative views on value transfers from pharmaceutical companies, with over half finding it unethical. More than two-thirds supported stricter regulations. Non-healthcare respondents were less favorable compared to healthcare professionals and those affiliated with pharmaceutical companies.
Conclusion
YDJ achieved substantial user engagement, and the embedded questionnaire survey revealed prevalent critical perspectives among users regarding value transfers from pharmaceutical companies to the healthcare sector. Non-healthcare or industry respondents, in particular, expressed the most negative views about such relationships.
期刊介绍：
Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments.
HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology.
Topics covered by HPT will include:
- Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems
- Cross-national comparisons on health policy using evidence-based approaches
- National studies on health policy to determine the outcomes of technology-driven initiatives
- Cross-border eHealth including health tourism
- The digital divide in mobility, access and affordability of healthcare
- Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies
- Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies
- Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making
- Stakeholder engagement with health technologies (clinical and patient/citizen buy-in)
- Regulation and health economics
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
